enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $6.99 million. The enterprise value is -$20.74 million.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 655,521 shares outstanding. The number of shares has increased by 20.20% in one year.
| Current Share Class | 655,521 |
| Shares Outstanding | 655,521 |
| Shares Change (YoY) | +20.20% |
| Shares Change (QoQ) | +7.18% |
| Owned by Insiders (%) | 9.07% |
| Owned by Institutions (%) | 12.73% |
| Float | 473,920 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.95 |
| PB Ratio | 0.25 |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.58, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.58 |
| Quick Ratio | 13.30 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.21% and return on invested capital (ROIC) is -36.77%.
| Return on Equity (ROE) | -56.21% |
| Return on Assets (ROA) | -35.06% |
| Return on Invested Capital (ROIC) | -36.77% |
| Return on Capital Employed (ROCE) | -76.16% |
| Weighted Average Cost of Capital (WACC) | 9.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$590,061 |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.11% in the last 52 weeks. The beta is 1.09, so enVVeno Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -87.11% |
| 50-Day Moving Average | 10.59 |
| 200-Day Moving Average | 47.48 |
| Relative Strength Index (RSI) | 45.79 |
| Average Volume (20 Days) | 17,955 |
Short Selling Information
The latest short interest is 79,901, so 12.19% of the outstanding shares have been sold short.
| Short Interest | 79,901 |
| Short Previous Month | 74,458 |
| Short % of Shares Out | 12.19% |
| Short % of Float | 16.86% |
| Short Ratio (days to cover) | 4.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.90M |
| Pretax Income | -19.47M |
| Net Income | -19.47M |
| EBITDA | -20.76M |
| EBIT | -20.90M |
| Earnings Per Share (EPS) | -$33.06 |
Full Income StatementBalance Sheet
The company has $28.21 million in cash and $700,000 in debt, with a net cash position of $27.51 million or $41.97 per share.
| Cash & Cash Equivalents | 28.21M |
| Total Debt | 700,000 |
| Net Cash | 27.51M |
| Net Cash Per Share | $41.97 |
| Equity (Book Value) | 27.13M |
| Book Value Per Share | 41.36 |
| Working Capital | 26.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.57 million and capital expenditures -$5,000, giving a free cash flow of -$15.57 million.
| Operating Cash Flow | -15.57M |
| Capital Expenditures | -5,000 |
| Depreciation & Amortization | 136,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -15.57M |
| FCF Per Share | -$23.76 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
